+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Phenylketonuria Treatment Market - Global Forecast 2025-2030- Product Image
Phenylketonuria Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Phenylketonuria Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968700
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Phenylketonuria Treatment Market is evolving rapidly as science, regulatory advances, and patient needs converge to redefine care strategies. Senior decision-makers face expanding opportunities and growing complexity, as innovations in gene therapy, enzyme substitution, and patient-centric models reshape how stakeholders engage across the continuum of care.

Market Snapshot: Phenylketonuria Treatment Market Overview

The Phenylketonuria Treatment Market grew from USD 765.13 million in 2024 to USD 821.45 million in 2025. It is expected to continue growing at a CAGR of 7.50%, reaching USD 1.18 billion by 2030. This trajectory reflects sustained investment in therapeutic innovation, a surge in precision medicine approaches, and increasing collaboration among industry, regulators, and advocacy organizations. The evolving reimbursement landscape, coupled with advances in supply chain resilience and regulatory frameworks, is shaping uptake and enabling broader access to novel treatments. As stakeholders respond to shifts in demographics and regional health policy, new opportunities are unfolding across technology adoption, clinical practice, and patient engagement.

Scope & Segmentation

This research provides an in-depth analysis of the phenylketonuria treatment landscape across therapy types, administration routes, patient demographics, and market channels, as well as geographic breakdowns and corporate activities.

  • Treatment Type: Gene therapy, enzyme substitution therapies, nutritional supplements, and pharmacological treatments including pegvaliase and sapropterin dihydrochloride.
  • Route of Administration: Oral and parenteral formulations, analyzed for impact on patient adherence and operational efficiency.
  • Age Group: Distinct strategies for adults (18+) and pediatric patients (0–17), reflecting developmental and clinical considerations.
  • Distribution Channel: Hospital pharmacies, online pharmacies, retail pharmacies, specialty clinics, and treatment centers.
  • Regions Covered: Americas (with country-level insight for the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (China, India, Japan, South Korea, Australia, and key ASEAN countries).
  • Companies Featured: Profiles and strategic movements for Abbott Laboratories, American Gene Technologies, APR Applied Pharma Research s.a., BioMarin Pharmaceuticals Inc, Codexis Inc., Nestlé S.A., Sanofi, and more.

Key Takeaways for Senior Leaders

  • Therapeutic innovation drives market evolution, with gene therapy and enzyme-based modalities positioned to address unmet clinical needs and enable disease modification.
  • Personalized medicine and early intervention are redefining the standard of care, fostering adaptive therapy regimens and elevating patient outcomes.
  • Regulatory agility and new approval frameworks are accelerating access to advanced therapies, supporting broader implementation across diverse health systems.
  • Integrated digital health platforms and telemedicine are improving patient engagement, adherence, and longitudinal monitoring, especially in underserved regions.
  • Collaborative alliances—spanning manufacturers, academic institutions, and advocacy groups—are reducing operational barriers and catalyzing R&D productivity.
  • Supply chain optimization and localized production strategies are increasingly critical as companies work to mitigate operational risks and ensure continuity.

Tariff Impact: Navigating Market Uncertainty

Imminent tariff policies on medical imports in the United States are prompting a strategic shift among manufacturers and payers. Companies are reassessing sourcing strategies, investing in regional manufacturing, and exploring risk-sharing agreements to offset increased costs. These policy-driven changes are accelerating diversification of product portfolios and stimulating the adoption of cost-effective alternatives such as nutraceutical interventions. Regulatory dialogue and international collaborations are vital to balancing trade constraints with equitable patient access, reinforcing the need for flexible supply chain and pricing models.

Methodology & Data Sources

This report synthesizes primary interviews with industry experts, secondary research from peer-reviewed sources, regulatory filings, and detailed clinical trial analysis. Data triangulation and quality control measures ensure actionable, validated insights for market assessment. Techniques include patient registry integration, review of health policy documents, and analysis of real-world evidence to inform market trends.

Why This Report Matters

  • Delivers actionable intelligence for developing targeted strategies, supporting investment decisions, and achieving competitive advantage in phenylketonuria care.
  • Enables organizational agility by illuminating the pathway from clinical development to commercial scale, accounting for regional, regulatory, and patient-centric considerations.
  • Supports scenario planning and risk mitigation amidst shifting global trade and reimbursement landscapes.

Conclusion

The phenylketonuria treatment market is entering a stage of intensified innovation, marked by collaborative alliances, technological advancements, and adaptive strategies. Decision-makers who prioritize flexibility and patient-centricity will be best equipped to navigate ongoing industry evolution and deliver sustainable impact across the care continuum.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of pegylated enzyme substitution therapies improving patient adherence and outcomes
5.2. Development of gene editing approaches targeting PAH gene mutations to provide one-time curative treatments
5.3. Advances in large neutral amino acid therapies designed to reduce phenylalanine brain uptake in adults
5.4. Emergence of digital health platforms enabling remote phenylalanine monitoring and dietary management
5.5. Strategic partnerships between specialty diet companies and biotech firms to innovate PKU medical nutrition
5.6. Regulatory approvals of mRNA-based therapies for phenylalanine hydroxylase restoration in PKU patients
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Phenylketonuria Treatment Market, by Treatment Type
8.1. Introduction
8.2. Gene Therapy & Enzyme Substitution Therapies
8.3. Nutritional Supplements
8.4. Pharmacological Treatment
8.4.1. Pegvaliase
8.4.2. Sapropterin Dihydrochloride
9. Phenylketonuria Treatment Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
10. Phenylketonuria Treatment Market, by Age Group
10.1. Introduction
10.2. Adults (18 years and above)
10.3. Pediatric (0-17 years)
11. Phenylketonuria Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
11.5. Specialty Clinics & Treatment Centers
12. Americas Phenylketonuria Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Phenylketonuria Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Phenylketonuria Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. American Gene Technologies
15.3.3. APR Applied Pharma Research s.a.
15.3.4. BioMarin Pharmaceuticals Inc
15.3.5. Codexis, Inc.
15.3.6. Daiichi Sankyo Co. Ltd.
15.3.7. Galen Limited
15.3.8. Homology Medicines, Inc.
15.3.9. Nestlé S.A.
15.3.10. PIAM Farmaceutici S.P.A.
15.3.11. Pluvia AS
15.3.12. PTC Therapeutics, Inc.
15.3.13. Relief Therapeutics Holding SA
15.3.14. Sanofi group
15.3.15. Synlogic
15.3.16. Travere Therapeutics, Inc.
15.3.17. Ultragenyx Pharmaceutical Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHENYLKETONURIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PHENYLKETONURIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PHENYLKETONURIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PHENYLKETONURIA TREATMENT MARKET: RESEARCHAI
FIGURE 24. PHENYLKETONURIA TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. PHENYLKETONURIA TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. PHENYLKETONURIA TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHENYLKETONURIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY GENE THERAPY & ENZYME SUBSTITUTION THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY GENE THERAPY & ENZYME SUBSTITUTION THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEGVALIASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEGVALIASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY SAPROPTERIN DIHYDROCHLORIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY SAPROPTERIN DIHYDROCHLORIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ADULTS (18 YEARS AND ABOVE), BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ADULTS (18 YEARS AND ABOVE), BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEDIATRIC (0-17 YEARS), BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PEDIATRIC (0-17 YEARS), BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS & TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHENYLKETONURIA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS & TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 47. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 48. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 57. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 58. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 59. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 60. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 69. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 70. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 71. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 72. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 73. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 76. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 77. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 78. CANADA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 79. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 80. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 81. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 82. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 83. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 84. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 85. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 86. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 87. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 88. MEXICO PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 89. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 90. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 91. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 92. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 100. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 101. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 102. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 122. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 124. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 131. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 132. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 133. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 134. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 135. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 138. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 139. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. GERMANY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 142. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 143. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 144. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 145. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 146. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 147. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 150. FRANCE PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 151. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 152. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 153. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 154. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 162. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 163. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 164. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 165. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 168. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 169. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. ITALY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 172. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 173. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 174. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 175. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. SPAIN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 192. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 194. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 202. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 204. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 211. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 212. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 213. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 214. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 215. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 216. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 217. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 218. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 219. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. DENMARK PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 222. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 223. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 224. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 232. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 233. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 234. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 235. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 236. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 237. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. QATAR PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 242. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 243. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 244. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 245. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 250. FINLAND PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 251. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 252. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 253. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 254. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 262. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 263. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 264. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 272. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 273. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 274. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 275. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 276. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 277. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 278. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 279. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. EGYPT PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 282. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 283. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 284. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 285. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 286. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 287. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 288. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 289. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. TURKEY PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 292. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 293. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 294. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL PHENYLKETONURIA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 301. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2024 (USD MILLION)
TABLE 302. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2025-2030 (USD MILLION)
TABLE 303. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2018-2024 (USD MILLION)
TABLE 304. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY PHARMACOLOGICAL TREATMENT, 2025-2030 (USD MILLION)
TABLE 305. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. NORWAY PHENYLKETONURIA TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. NORWAY PHENYLKETONURIA TREATMENT MARKET S

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • American Gene Technologies
  • APR Applied Pharma Research s.a.
  • BioMarin Pharmaceuticals Inc
  • Codexis, Inc.
  • Daiichi Sankyo Co. Ltd.
  • Galen Limited
  • Homology Medicines, Inc.
  • Nestlé S.A.
  • PIAM Farmaceutici S.P.A.
  • Pluvia AS
  • PTC Therapeutics, Inc.
  • Relief Therapeutics Holding SA
  • Sanofi group
  • Synlogic
  • Travere Therapeutics, Inc.
  • Ultragenyx Pharmaceutical Inc.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 821.45 Million
Forecasted Market Value ( USD ) by 2030 $ 1180 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Phenylketonuria Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034) - Product Image

Phenylketonuria Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

  • Report
  • 400 Pages
  • Global
From
Phenylketonuria Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Phenylketonuria Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq), By Mode of Administration (Oral Administration, Parenteral Administration), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Phenylketonuria Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Phenylketonuria Treatment Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 75 Pages
  • Global
From
Phenylketonuria Treatment - Global Strategic Business Report - Product Image

Phenylketonuria Treatment - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From

About the Phenylketonuria Drug Market

Phenylketonuria (PKU) is a rare genetic disorder that affects the metabolism of the amino acid phenylalanine. It is treated with a special diet and medication. Endocrine and Metabolic Disorders Drugs are used to treat a variety of conditions, including PKU. These drugs are designed to help the body regulate hormones, enzymes, and other substances that are essential for normal functioning. The Phenylketonuria Drug market is composed of a variety of products, including enzyme replacement therapy, dietary supplements, and drugs that reduce phenylalanine levels. These drugs are used to treat the symptoms of PKU and to prevent further complications. The market is highly competitive, with many companies offering different products. Some of the companies in the Phenylketonuria Drug market include Biomarin Pharmaceuticals, Amicus Therapeutics, and BioMarin Pharmaceuticals International. Other companies include Genzyme Corporation, Shire Pharmaceuticals, and Sanofi-Aventis. These companies are dedicated to providing innovative treatments for PKU and other endocrine and metabolic disorders. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.